KUALA LUMPUR: HARTALEGA HOLDINGS BHD []'s earnings rose 32.1% to RM49.20 million in the third quarter ended Dec 31, 2010 compared with RM37.2 0 million a year ago.
It said on Monday, Feb 7 revenue rose 26.5% to RM188.12 million from RM148.59 million while pre-tax profit increased by 31% to RM62.21 million from RM47.47 million. Earnings per share were 13.54 sen versus 10.23 sen. It declared an interim dividend of five sen.
'The significant achievement in revenue and profit before tax is in line with the group's continuous expansion in production capacity, increase in demand, effective cost control and improvement in production processes,' it said.
Hartalega said its group's products were sold to the healthcare industry. It added glove consumption was inelastic in the medical environment because the usage of glove is mandatory for disease control.
'Our nitrile synthetic glove was well accepted by the end users due to its high quality and elastic PROPERTIES [] that mimic that of a natural rubber glove. Our protein free and competitive priced nitrile glove has made it more affordable for the acute healthcare industry to continue switching from the natural rubber to our synthetic nitrile glove to avoid the protein allergy problem,' it said.
Hartalega had also commissioned three more new advanced high capacity glove production lines for the current quarter ended Dec 31, 2010, the last production line from Plant 5 was commissioned in January 2011.
It said on Monday, Feb 7 revenue rose 26.5% to RM188.12 million from RM148.59 million while pre-tax profit increased by 31% to RM62.21 million from RM47.47 million. Earnings per share were 13.54 sen versus 10.23 sen. It declared an interim dividend of five sen.
'The significant achievement in revenue and profit before tax is in line with the group's continuous expansion in production capacity, increase in demand, effective cost control and improvement in production processes,' it said.
Hartalega said its group's products were sold to the healthcare industry. It added glove consumption was inelastic in the medical environment because the usage of glove is mandatory for disease control.
'Our nitrile synthetic glove was well accepted by the end users due to its high quality and elastic PROPERTIES [] that mimic that of a natural rubber glove. Our protein free and competitive priced nitrile glove has made it more affordable for the acute healthcare industry to continue switching from the natural rubber to our synthetic nitrile glove to avoid the protein allergy problem,' it said.
Hartalega had also commissioned three more new advanced high capacity glove production lines for the current quarter ended Dec 31, 2010, the last production line from Plant 5 was commissioned in January 2011.
No comments:
Post a Comment